Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans:
2019
BackgroundLasmiditan demonstrated superiority to placebo in the acute treatment of migraine in adults with moderate/severe migraine disability in two similarly designed Phase 3 trials, SAMURAI and ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
25
References
18
Citations
NaN
KQI